medicine for chronic lymphocytic leukemia

TORITZ 100MG INJ

TORITZ 100MG INJ is a Schedule H drug. TORITZ 100MG INJ is composed of: RITUXIMAB (100.0 MG)

RITUXIREL 500MG INJ is a Schedule H drug. RITUXIREL 500MG INJ is composed of: RITUXIMAB (500.0 MG)

RITUXIREL 100MG INJ is a Schedule H drug. RITUXIREL 100MG INJ is composed of: RITUXIMAB (100.0 MG)

RISTOVA 500MG INJ is a Schedule H drug. RISTOVA 500MG INJ is composed of: RITUXIMAB (500.0 MG)

RISTOVA 100MG INJ is a Schedule H drug. RISTOVA 100MG INJ is composed of: RITUXIMAB (100.0 MG)

REDITUX RA 500MG INFUSION is a Schedule H drug. REDITUX RA 500MG INFUSION is composed of: RITUXIMAB (500.0 MG)

REDITUX 500MG INJ is a Schedule H drug. REDITUX 500MG INJ is composed of: RITUXIMAB (500.0 MG)

REDITUX 100MG INJ is a Schedule H drug. REDITUX 100MG INJ is composed of: RITUXIMAB (100.0 MG)

MABTAS T 500MG INJ is a Schedule H drug. MABTAS T 500MG INJ is composed of: RITUXIMAB (500.0 MG)

MABTAS T 100MG INJ is a Schedule H drug. MABTAS T 100MG INJ is composed of: RITUXIMAB (100.0 MG)